BioDigital has received a $4 million Series A round of funding led by venture capital firm FirstMark Capital, with participation from the NYU Innovation Venture Fund at New York University and a group of angel investors.

Back in 2002, BioDigital was founded on the premise that 3D technology could transform the way we understand health and medicine. The founders had witnessed its impact on gaming and Hollywood, and were determined to apply state-of-the-art 3D to healthcare as well. Together they opened BioDigital Systems - a biomedical visualization company - in New York City, and over the years, they have helped make biomedical information more accessible for a diverse list of clients, including hospitals, biotech and medical device companies, pharmaceuticals, non-profit organizations, and academic institutions.